Know Labs, Inc. (KNWN)
- Business Wire
New Test Data Confirm Particle™ Bulb from Know Labs Successfully Inactivates SARS-CoV-2 Variants
SEATTLE, October 13, 2021--Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today announced that new independent test data have confirmed the efficacy of a light bulb produced by its wholly owned subsidiary Particle, Inc., in inactivating multiple variants of SARS-CoV-2, the virus that causes COVID-19. The data are based on tests performed by Texas Biomedical Research Institute (Texas Biomed).
- Business Wire
New Tests Show Know Labs Bio-RFID™ Technology Delivers Blood Glucose Readings Comparable to FDA-Cleared Devices
SEATTLE, October 06, 2021--Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today published a new report on its non-invasive platform technology, Bio-RFIDTM, comparing its clinical accuracy to FDA-cleared glucose monitoring devices that are currently available in the market.
- Business Wire
Know Labs Expands Non-Invasive Glucose Monitoring Product Portfolio with Introduction of New KnowU™ Diagnostic Device
SEATTLE, September 22, 2021--Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today introduced the KnowU™, a new portable medical-grade glucose monitoring device that utilizes Bio-RFID™, Know Labs’ non-invasive diagnostic technology.
